[Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
alpha-2A-interferon is a useful and safe drug in Kaposi's sarcoma treatment although not free of serious side-effects when used at therapeutic dosages by which strict controls must be undertaken. When treatment has been interrupted, worsening and dissemination of the disease happened. No correlation has been found between immunologic parameters and the treatment used.
Lopez Bran
E
E
Departamento de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario San Carlos, Madrid.
Aguilar
R
R
Marron
J A
JA
Figueredo
M A
MA
Garcia Ruiz
J M
JM
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000150:complications / Q000628:therapy*
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Tratamiento de cinco pacientes afectos de sarcoma de Kaposi y SIDA con interferon recombinante alfa-2A (roferon-A).